Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

ASTRAZENECA (AZN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
06/18/2018 06/19/2018 06/20/2018 06/21/2018 06/22/2018 Date
5383(c) 5363(c) 5379(c) 5255(c) 5229(c) Last
2 298 123 2 099 715 2 302 420 2 599 530 3 031 005 Volume
-0.28% -0.37% +0.30% -2.31% -0.49% Change
More quotes
Financials (USD)
Sales 2018 22 361 M
EBIT 2018 5 330 M
Net income 2018 1 982 M
Debt 2018 14 629 M
Yield 2018 3,96%
Sales 2019 23 874 M
EBIT 2019 6 307 M
Net income 2019 2 734 M
Debt 2019 15 214 M
Yield 2019 4,01%
P/E ratio 2018 36,60
P/E ratio 2019 29,59
EV / Sales2018 4,58x
EV / Sales2019 4,31x
Capitalization 87 758 M
More Financials
Company
AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products.The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases.Its... 
Sector
Pharmaceuticals
Calendar
06/24 | 06:00pmPresentation
More about the company
Surperformance© ratings of AstraZeneca
Trading Rating : Investor Rating :
More Ratings
Latest news on ASTRAZENECA
06/22ASTRAZENECA : to share latest data from an industry-leading portfolio that aims ..
AQ
06/22ASTRAZENECA : Publication of a Prospectus
AQ
06/21STUDIES FROM ASTRAZENECA PROVIDE NEW : ...
AQ
06/21ASTRAZENECA : Researchers from AstraZeneca Describe Findings in Opioids (Resourc..
AQ
06/21Initiating Free Research Reports on Bristol-Myers Squibb and Three Other Drug..
AC
06/21ASTRAZENECA : With an AstraZeneca cancer drug in one hand, $37M in the other, Sh..
AQ
06/20ASTRAZENECA : Scotland to house world-first manufacturing innovation centre
AQ
06/19FASTER MEDICINE : 56 million innovation centre for Scotland
AQ
06/19ASTRAZENECA : to Share Latest Data from an Industry-Leading Portfolio That Aims ..
BU
06/19ASTRAZENECA : Medicines manufacturing centre planned to strengthen UK pharma
AQ
More news
Sector news : Pharmaceuticals - NEC
06/22Federal Judge Gives Lilly Win on Alimta Regimen Patent
DJ
06/22JOHNSON & JOHNSON : Remakes Top Leadership -- Update
DJ
06/22JOHNSON & JOHNSON : Worldwide Chairman Peterson to Retire
DJ
06/22SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
06/22Roche to Appoint James Sabry as Head of Partnering
DJ
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on ASTRAZENECA 
ASTRAZENECA - 2016
A rally could take place
BUY
More Strategies
Latest Tweets
06/22Yesterday, the audience voted for Kalium Diagnostics as the winner of our i..
10
06/21The winner of the first AstraZeneca Start-Up Science competition is Kalium Di..
4
06/21Shamus Husheer from Heartfelt Technologies and Shaun Grady, our Vice-Presiden.. 
06/21Nick Brown, Head of AI & Data Sciences at AstraZeneca says “we now work w.. 
06/21"In those days there was less interest, but we needed a collaboration to take..
1
More tweets
Qtime:116
News from SeekingAlpha
09:35aWEEK IN REVIEW : CITIC Offers $3.6 Billion To Acquire China Biologic 
08:00a3 THINGS IN BIOTECH, JUNE 23 : Regeneron Spiders Out With Inovio, Synairgen Prov.. 
06/23What Does Breakthrough Therapy Designation Really Mean For My Company? 
06/21Neon Therapeutics Firms Its Plan For $100 Million IPO 
06/19ALZHEIMER'S DISEASE : A History Of Drug Failures 
Chart ASTRAZENECA
Duration : Period :
AstraZeneca Technical Analysis Chart | AZN | GB0009895292 | 4-Traders
Technical analysis trends ASTRAZENECA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 31
Average target price 74,5 $
Spread / Average Target 7,4%
EPS Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Dunoyer Chief Financial Officer & Executive Director
Sean Bohen Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA2.11%87 758
JOHNSON & JOHNSON-12.08%329 475
PFIZER0.22%213 568
NOVARTIS-9.42%191 991
ROCHE HOLDING LTD.-10.81%191 785
MERCK AND COMPANY9.24%165 373